The Patent Finder

Aragon Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Aragon Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 37 patents it holds.

Showing 1 to 8 of 8 · Back to Aragon Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,285,948Anticancer Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,023,556Androgen Receptor Modulators and Uses Thereof
Lapsed on the fee record
Ended Jul 17, 2026 · High confidence
Lapsed on the fee recordEnded Jul 17, 2026High confidence
US 9,617,602Methods and compositions for determining resistance to androgen receptor therapy
Lapsed on the fee record
Ended Apr 11, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 11, 2025USPTO record
US 9,481,664Androgen Receptor Modulators and Uses Thereof
Lapsed on the fee record
Ended Nov 1, 2024 · High confidence
Lapsed on the fee recordEnded Nov 1, 2024High confidence
US 9,108,944Androgen Receptor Modulators and Uses Thereof
Lapsed on the fee record
Ended Aug 18, 2023 · High confidence
Lapsed on the fee recordEnded Aug 18, 2023High confidence
US 10,052,314Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer
Surrendered on reissue
Surrendered on reissue Jan 3, 2023 · Low confidence
Surrendered on reissueSurrendered on reissue Jan 3, 2023Low confidence
US 8,853,423Indane estrogen receptor modulators and uses thereof
Lapsed on the fee record
Ended Oct 7, 2022 · USPTO record
Lapsed on the fee recordEnded Oct 7, 2022USPTO record
US 9,855,270Methods and Compositions for Modulating Estrogen Receptor Mutants
Formerly held
Lapsed on the fee record
Ended Jan 2, 2022 · Medium confidence
Lapsed on the fee recordEnded Jan 2, 2022Medium confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited